在轻微的中风中,将IV血栓溶解添加到非血栓溶解常规护理中,不会增加90d的优良功能结果
Avi Singh Gandh1, Mithilesh Siddu1, Dinesh Jillella1
1Emory University and Grady Memorial Hospital, Atlanta, Georgia, USA (A.S.G., M.S., D.J.).
Annals of internal medicine
|November 3, 2025
概括
这项研究评估了紧急医疗,一般内科/家庭医疗/全科医疗和神经病学的临床影响评级. 发现被分类,以告知不同的医学专业.
科学领域:
- 紧急医疗 紧急医疗
- 一般的内科医学一般内科医学.
- 家庭练习 家庭练习
- 一般的做法一般的做法
- 神经学 神经学
背景情况:
- 临床影响评级对于优先考虑医学研究和资源分配至关重要.
- 了解不同专业的这些评级有助于基于证据的实践.
研究的目的:
- 系统地评估和分类临床影响等级.
- 为了提供一个清晰的概述影响在紧急医疗,GIM/FP/GP,神经病学.
主要方法:
- 对临床影响数据的分析.
- 根据每个医学专业的预定义标准进行分类.
主要成果:
- 紧急医疗的具体影响评级被确定.
- 对一般内科/家庭医生/全科医生建立了影响评级.
- 神经学也获得了特定的临床影响评级.
结论:
- 该研究提供了对关键医学领域临床影响的结构化评估.
- 这些评级可以指导未来的研究方向和临床决策.
相关概念视频
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
298
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
298
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Peripheral Artery Disease III: Interprofessional Care
232
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
232
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K


